Drugs Made In America Acquisition Corp. - RIGHT 10/15/2029 (DMAAR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q3 2025

Type / Class
Equity / RIGHT 10/15/2029
Symbol
DMAAR on Nasdaq
Price per share
$0.20
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
17,746,646
Total reported value
$7,163,761
% of total 13F portfolios
0%
Share change
-1,151,904
Value change
+$3,207,674
Number of holders
33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 33 institutional investors reported holding 17,746,646 shares of Drugs Made In America Acquisition Corp. - RIGHT 10/15/2029 (DMAAR).

Institutional Holders of Drugs Made In America Acquisition Corp. - RIGHT 10/15/2029 (DMAAR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 17,746,646 $7,163,761 +$3,207,674 $0.22 33
2025 Q2 18,277,728 $2,217,081 +$501,585 $0.12 24
2025 Q1 14,151,554 $2,529,405 +$2,529,386 $0.13 19